Stay updated on Pfizer Press Releases

Sign up to get notified when there's something new on the Pfizer Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Pfizer Press Releases page

  1. Check
    5 days ago
    Change Detected
    Summary
    Three new press releases dated 04.29.2026, 04.28.2026, and 04.23.2026 have been added to the Pfizer Press Release Archive. The update also removes older entries from February and March 2026, updating the list of recent announcements in the archive.
    Difference
    8%
    Check dated 2026-05-01T10:05:55.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    Updated the press release archive list by adding new entries for **04.20–04.22.2026**, including a **second-quarter 2026 dividend declaration** and **U.S. FDA priority review** related to PADCEV™ + Keytruda®, and an **ASCO 2026 oncology pipeline** update. It also removed earlier items dated **02.06–02.23.2026** from the archive results.
    Difference
    8%
    Check dated 2026-04-24T06:17:17.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    A new press release invitation for Pfizer’s April 23, 2026 annual meeting webcast was added to the archive, and an older press release was removed.
    Difference
    2%
    Check dated 2026-04-09T21:35:33.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    Added a dedicated Press Release Archive page and removed the Press Releases and News navigation options, restructuring how press content is accessed.
    Difference
    0.4%
    Check dated 2026-04-02T15:30:31.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    Adds four March 2026 press releases to the archive and removes older January–February 2026 entries.
    Difference
    8%
    Check dated 2026-03-26T11:30:44.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Summary
    Added Research and Research and Pipeline categories and included the March 17, 2026 press release Pfizer Announces Positive Topline Phase 2 Results for Next-Generation CDK4 Inhibitor, Atirmociclib, in Second-Line Metastatic Breast Cancer. Removed Finance and Financial categories and deleted the February 3 conference call webcast entry from December 2025.
    Difference
    2%
    Check dated 2026-03-19T05:07:34.000Z thumbnail image

Stay in the know with updates to Pfizer Press Releases

Enter your email address, and we'll notify you when there's something new on the Pfizer Press Releases page.